HD Cannulation PRO v.1
Research type
Research Study
Full title
A Study to Develop a Questionnaire to Capture Patients’ Perspectives of Cannulation of Arteriovenous Access for Haemodialysis
IRAS ID
269188
Contact name
Catherine Fielding
Contact email
Sponsor organisation
University Hospitals of Derby and Burton NHS Foundation Trust
Duration of Study in the UK
0 years, 4 months, 2 days
Research summary
Patients with kidney failure require haemodialysis three times a week, for a period of years. An essential part of this treatment is the insertion of 2 needles into a vein (aka cannulation) to allow the treatment to be performed. Research has found that this needle insertion is associated with fear, pain and anxiety. There is no known questionnaire to capture patients' perspectives of needle insertion for haemodialysis.
This study will develop and test a questionnaire to capture patients' perspectives of needle insertion for haemodialysis. It is the second phase of a feasibility study. Within this study, patients' perspectives includes patients' opinions, symptoms and experiences of the procedure.
The questionnaire will be developed using patient representatives to discuss and adapt themes developed from a systematic review (PROSPERO No.CRD42019134583). Once developed, the questionnaire will be administered to patients on three occasions. On one occasion a second questionnaire will also be administered. The data from these questionnaires will provide data for four tests, to demonstrate it measures what we are aiming to measure consistently. These questionnaire tests are know as face validity, internal consistency, convergent validity and test-retest reliability.
This study will include patients who are undergoing regular haemodialysis using an arteriovenous fistula or graft. It will recruit participants from 2 sites - Derby and Nottingham.
Initially 12 patients, 6 at each site will be asked to complete the draft questionnaire alongside questions to test face validity. This questionnaire will take approximately 20 minutes to complete.
Following this, at each site, a maximum of 100 participants, 50 patients at each site, will be asked to complete three questionnaires on two occasions. This is expected to take a maximum of fifteen minutes on the first occasion and ten minutes on the second occasion, over a maximum period of 6 days.
REC name
London - Fulham Research Ethics Committee
REC reference
19/LO/1488
Date of REC Opinion
24 Oct 2019
REC opinion
Favourable Opinion